Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Patent
1993-07-22
1995-11-21
Datlow, Philip I.
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
540512, 548125, 548456, 548463, 548465, 548466, 548482, 549223, 549290, 549394, 564361, 564428, 436503, C07D48704, C07D51900
Patent
active
054688540
ABSTRACT:
Conjugates of fluorescent labels with specific, selective, and high affinity ligands for receptors have been synthesized and used to directly measure binding to receptors. In the examples, fluorescein conjugates of the high-affinity benzodiazepine receptor ligands Ro 15-1788 and Ro 7-1986 were synthesized. The binding of these fluorescent ligands (BD 621, BD 623 and BD 607) to benzodiazepine receptors was characterized by direct fluorescence measurement. Both the equilibrium dissociation constants (K.sub.D) of BD 621 and BD 607 and the maximum number of binding sites (B.sub.max) estimated by fluorescence monitoring were consistent with values obtained by using radioligand binding techniques. The binding of BD 621 and BD 607 assessed by fluorescence measurement was reversible, abolished by photoaffinity labeling with Ro 15-4513, and unaffected by a variety of substances that do not bind to benzodiazepine receptors. The potencies of chemically diverse benzodiazepine receptor compounds to inhibit fluorescent ligand binding were highly correlated, with potencies obtained from radioligand binding techniques. These findings demonstrate that direct fluorescence measurement techniques can be used to quantitate ligand-receptor interactions.
REFERENCES:
The Merck Index, 11th ed. (1989), Merck & Co., Inc., Rahway, N.J., pp. 401, 442, 646, 651, 1301.
R. Tyler McCabe, et al., Synapse:2:163-173 (1988).
R. Tyler McCabe, et al., Pharmacology Biochemistry & Behavior, vol. 37, pp. 365-370 (1990).
R. W. Olsen, et al., J. Chem. Neuroanatomy, vol. 3:59-76 (Jan. 1990).
R. H. Havunjian, et al., J. Biol. Chem. 265(36):22181-22186 (1990).
R. Tyler McCabe, et al., Faseb J. 4:2934-2940 (1990).
Correa, F. M. A., et al., Neurosci. Lett. 16, 47-53 (1990).
Atlas, D., and Levitzki, A., Proc. Natl. Acad. Sci. USA 74,5290-5294 (1977).
Henis, Y. I., et al. Proc. Natl. Acad. Sci. USA 79, 2907-2911 (1982).
Rademaker, B., et al., Res. Commun. Chem. Pathol. Pharmacol. 60, 147-159 (1988).
Kolb, V. M., et al., Life Sci. 33, 423-426 (1983).
Jacobson, K. A., Biochem. Pharmacol. 36, 1697-1707 (1987).
Heithier, H., et al., Biochim. Biophys. Acta 971, 298-306 (1988).
Ward, L. D., et al., Biochim. Biophys. Acta 971, 307-316 (1988).
Carlson, K. E., et al., J. Steroid Biochem. 32, 345-355 (1989).
Monsma, F. J., Jr., et al., J. Neurochem. 52, 1641-1644 (1989).
Velasquez, et al., J. Neurosci. 9:2163-2169 (1989).
Ariano, et al., Proc. Natl. Acad. Sci. USA 86:8570-8574 (1989).
de Costa Brian R.
McCabe R. Tyler
Datlow Philip I.
Pharmaceutical Discovery Corporation
LandOfFree
Characterization of specific drug receptors with fluorescent lig does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Characterization of specific drug receptors with fluorescent lig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Characterization of specific drug receptors with fluorescent lig will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1138305